Pathologic significance of tumor progression in locally recurrent rectal cancer: Different nature from primary cancer

Diseases of the Colon and Rectum

Volumn 43, Issue 6, 2000, Pages 775-781

  Onodera, H ^a   Maetani, S ^b   Kawamoto, K ^a   Kan, S ^a   Kondo, S ^a   Imamura, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Tenri Institute of Medical Research   (Japan)

Author keywords

Angiogenesis; Apoptosis; Locally recurrent rectal cancer; PCNA labeling index; Prognostic factor; Survival

Indexed keywords

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; RECTUM CANCER; TUMOR GROWTH;

EID: 0034044268     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238013     Document Type: Article

References (43)

1. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995;10:126-32.
2. Rullier E, Laurent C, Carles J, Saric J, Michel P, Parneix M. Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg 1997;84: 525-8.
3. Romano G, Rotondano G, D'Alessandro V, et al. Pelvic recurrence following resection of rectal cancer: a multivariate predictive model. Int Surg 1997;82:67-71.
4. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum - an endangered operation. Norman Nigro lectureship. Dis Colon Rectum 1997;40:747-51.
5. James RD, Johnson RJ, Eddelston B, Zheng GL, Jones JM. Prognostic factors in locally recurrent rectal carcinoma treated by radiotherapy. Br J Surg 1983;70: 469-72.
6. Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997;38:785-90.
7. Farouk R, Nelson H, Gunderson LL. Aggressive multi-modality treatment for locally advanced irresectable rectal cancer. Br J Surg 1997;84:741-9.
8. Goes RN, Beart RW Jr, Simons AJ, Gunderson LL, Grado G, Streeter O. Use of brachytherapy in management of locally recurrent rectal cancer. Dis Colon Rectum 1997; 40:1177-9.
9. Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 1987;205:482-95.
10. Steel G Jr, Ravikumar TS, Benotti PN. New surgical treatments for recurrent colorectal cancer. Cancer 1990; 65:723-30.
11. Temple WJ, Ketcham AS. Sacral resection for control of pelvic tumors. Am J Surg 1992;163:370-4.
12. Wanebo HJ, Koness RJ, Vezeridis MP, Coen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586-97.
13. Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 1995;82:1401-5.
14. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39:323-8.
15. Hoffman JP, Riley L, Carp NZ, Litwin S. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 1993;20:506-19.
16. Schneebaum S, Arnold MW, Young D, et al. Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer. Dis Colon Rectum 1993;36: 810-5.
17. Maetani S, Nishikawa T, Iijima Y, et al. Extensive en bloc resection of regionally recurrent carcinoma of the rectum. Cancer 1992;69:2876-83.
18. Maetani S, Onodera H, Nishikawa T, et al. The significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998;85:521-5.
19. Folkman J. Angiogenesis and angiogenesis inhibitor: an overview. EXS 1997;79:1-8.
20. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
21. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-26.
22. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
23. Welin S, Youker J, Spratt JS Jr. The rates and patterns of the large intestine and rectum observed serially by double-contrast enema study (Malmo technique). Am J Roentgenol Radium Ther Nucl Med 1963;90:673-87.
24. Bolin S, Nilsson E, Sjödahl R. Carcinoma of the colon and rectum - growth rate. Ann Surg 1983;198:151-8.
25. Staah HJ, Anderer FA, Stumph E, Fisher R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. 1978;136:324-7.
26. Bosari S, Lee AK, Dellellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23: 755-61.
27. Bozzetti F, Bertario L. Rossetti C, et al. Surgical treatment of locally recurrent rectal cancer. Dis Colon Rectum 1997;40:1421-4.
28. Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer - is it worthwhile? Dis Colon Rectum 1997; 40:150-5.
29. Suzuki K, Dorozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39: 730-6.
30. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996;83:293-304.
31. Scholefield JH, Northover JMA. Surgical management of rectal cancer. Br J Surg 1995;82:745-8.
32. Lindmark G, Gerdin B, Sundberg C, Påhlman L, Bergstrom R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461-6.
33. Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, O'Malley FP. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996;20:1260-5.
34. Frank RE, Sacclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995;222:695-9.
35. Tanigawa N, Amaya H, Matumura M, Lu C, Kitaoka A, Matuyama K, Muraoka R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997;57:1043-6.
36. Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenoma and carcinoma with clinicopathological correlations. Cancer Res 1995;55:5049-53.
37. Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal cancer occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-7.
38. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996;379:88-91.
39. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71: 2454-60.
40. Liao G, Zhang Y, Shen M, Jiang H, Yan Z. Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer. Dis Colon Rectum 1997; 40:1489-93.
41. Al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993:71:1954-9.
42. Neoptolemos JP, Oates GD, Newbold KM, Robson AM, McConkey C, Powell J. Cyclin/proliferative cell nuclear immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classification for colorectal cancer. Br J Surg 1995;82:184-7.
43. Kawamoto K, Onodera H, Kondo S, et al. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 1998;55:242-8.